Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies

Memorial Sloan Kettering Cancer Center, New York

Weill Cornell Medical College, New York

H. Lee Moffitt Cancer Center, Tampa

Meir Medical Center, Kfar Saba

Mayo Clinic, Rochester

CHU Hôpital Lyon Sud, Lyon

Centre Henri Becquerel, Rouen

University of California, Irvine, Orange

Stanford University, Stanford

Institut Gustave Roussy, Villejuif

Universitatsklinikum Wurzburg, Würzburg

Rambam Health Care Campus - Hematology and Bone Marrow Transplantation Institute, Haifa

Lady Davis Carmel Medical Center, Haifa

The Chaim Sheba Medical Center, Tel-Hashomer

Assuta Ashdod University Hospital, Ashdod

Hadassah Medical Center, Jerusalem

Massachusetts General Hospital, Boston

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute (Massachusetts General Hospital and Beth Israel), Boston

Rutgers Cancer Institute of New Jersey, New Brunswick

Royal Cornwall Hospitals NHS Trust, Truro

The Christie NHS Foundation Trust, Manchester